Thread by @drharshvardhan

Drug Controller General of India has given approval to the first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine. This is the first indigenously developed vaccine in the field of #pneumonia

@CDSCO_INDIA_INF @MoHFW_INDIA

This vaccine has been developed by M/s. Serum Institute of India Pvt. Ltd, Pune. @SerumInstIndia first obtained the approval of DCGI to conduct Phase I, Phase II & Phase III clinical trials of Pneumococcal Polysaccharide Conjugate #Vaccine in India
@CDSCO_INDIA_INF @MoHFW_INDIA

Earlier the demand of such #vaccine was substantially met by licensed importers in the country since the manufacturers were all vaccine companies based outside India.
#AtmaNirbharBharat
@MoHFW_INDIA @SerumInstIndia @CDSCO_INDIA_INF